Russia develops breakthrough mRNA-based cancer vaccine

Russian scientists have taken a major step forward in the fight against cancer by developing a new vaccine named “Entemix”, based on mRNA technology. According to the Federal Medical and Biological Agency (FMBA), the vaccine has already shown promising pre-clinical trial results.

FMBA head Veronika Skvortsova revealed that after three years of research, the vaccine proved to be safe and highly effective, reducing the growth of cancer tumors by 60% to 80% in test subjects. It also significantly improved survival rates.

The vaccine primarily targets colon cancer in its first phase. At the same time, scientists are also working on developing versions of the vaccine to treat brain cancer (glioblastoma), eye cancer, and skin cancer (melanoma).

Interestingly, the vaccine uses the same mRNA technology that was applied in COVID-19 vaccines. This method trains the body’s immune system to produce proteins that attack and destroy cancer cells. Researchers believe this could open new doors in treating some of the deadliest forms of cancer.